150 related articles for article (PubMed ID: 25424656)
1. Theoretical study of the mechanism of protein arginine deiminase 4 (PAD4) inhibition by F-amidine.
Li D; Liu C; Lin J
J Mol Graph Model; 2015 Feb; 55():25-32. PubMed ID: 25424656
[TBL] [Abstract][Full Text] [Related]
2. Active site cysteine is protonated in the PAD4 Michaelis complex: evidence from Born-Oppenheimer ab initio QM/MM molecular dynamics simulations.
Ke Z; Zhou Y; Hu P; Wang S; Xie D; Zhang Y
J Phys Chem B; 2009 Sep; 113(38):12750-8. PubMed ID: 19507815
[TBL] [Abstract][Full Text] [Related]
3. Haloacetamidine-based inactivators of protein arginine deiminase 4 (PAD4): evidence that general acid catalysis promotes efficient inactivation.
Knuckley B; Causey CP; Pellechia PJ; Cook PF; Thompson PR
Chembiochem; 2010 Jan; 11(2):161-5. PubMed ID: 20014086
[TBL] [Abstract][Full Text] [Related]
4. A fluoroacetamidine-based inactivator of protein arginine deiminase 4: design, synthesis, and in vitro and in vivo evaluation.
Luo Y; Knuckley B; Lee YH; Stallcup MR; Thompson PR
J Am Chem Soc; 2006 Feb; 128(4):1092-3. PubMed ID: 16433522
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.
Luo Y; Arita K; Bhatia M; Knuckley B; Lee YH; Stallcup MR; Sato M; Thompson PR
Biochemistry; 2006 Oct; 45(39):11727-36. PubMed ID: 17002273
[TBL] [Abstract][Full Text] [Related]
6. Theoretical insights into the protonation states of active site cysteine and citrullination mechanism of Porphyromonas gingivalis peptidylarginine deiminase.
Zhao C; Ling B; Dong L; Liu Y
Proteins; 2017 Aug; 85(8):1518-1528. PubMed ID: 28486790
[TBL] [Abstract][Full Text] [Related]
7. Protein arginine deiminase 4: evidence for a reverse protonation mechanism.
Knuckley B; Bhatia M; Thompson PR
Biochemistry; 2007 Jun; 46(22):6578-87. PubMed ID: 17497940
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.
Jones JE; Slack JL; Fang P; Zhang X; Subramanian V; Causey CP; Coonrod SA; Guo M; Thompson PR
ACS Chem Biol; 2012 Jan; 7(1):160-5. PubMed ID: 22004374
[TBL] [Abstract][Full Text] [Related]
9. The electrostatic driving force for nucleophilic catalysis in L-arginine deiminase: a combined experimental and theoretical study.
Li L; Li Z; Wang C; Xu D; Mariano PS; Guo H; Dunaway-Mariano D
Biochemistry; 2008 Apr; 47(16):4721-32. PubMed ID: 18366187
[TBL] [Abstract][Full Text] [Related]
10. Development and use of clickable activity based protein profiling agents for protein arginine deiminase 4.
Slack JL; Causey CP; Luo Y; Thompson PR
ACS Chem Biol; 2011 May; 6(5):466-76. PubMed ID: 21265574
[TBL] [Abstract][Full Text] [Related]
11. Born-Oppenheimer ab initio QM/MM molecular dynamics simulations of the hydrolysis reaction catalyzed by protein arginine deiminase 4.
Ke Z; Wang S; Xie D; Zhang Y
J Phys Chem B; 2009 Dec; 113(52):16705-10. PubMed ID: 20028143
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel PAD4 inhibitors based on a pharmacophore model derived from transition state coordinates.
Wei Y; Liu R; Liu C; Jin J; Li D; Lin J
J Mol Graph Model; 2017 Mar; 72():88-95. PubMed ID: 28064083
[TBL] [Abstract][Full Text] [Related]
13. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.
Knuckley B; Causey CP; Jones JE; Bhatia M; Dreyton CJ; Osborne TC; Takahara H; Thompson PR
Biochemistry; 2010 Jun; 49(23):4852-63. PubMed ID: 20469888
[TBL] [Abstract][Full Text] [Related]
14. Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis.
Kearney PL; Bhatia M; Jones NG; Yuan L; Glascock MC; Catchings KL; Yamada M; Thompson PR
Biochemistry; 2005 Aug; 44(31):10570-82. PubMed ID: 16060666
[TBL] [Abstract][Full Text] [Related]
15. Role of peptidylarginine deiminase 4 (PAD4) in pig parthenogenetic preimplantation embryonic development.
Brahmajosyula M; Miyake M
Zygote; 2013 Nov; 21(4):385-93. PubMed ID: 22793990
[TBL] [Abstract][Full Text] [Related]
16. Structural and biochemical analyses of the human PAD4 variant encoded by a functional haplotype gene.
Horikoshi N; Tachiwana H; Saito K; Osakabe A; Sato M; Yamada M; Akashi S; Nishimura Y; Kagawa W; Kurumizaka H
Acta Crystallogr D Biol Crystallogr; 2011 Feb; 67(Pt 2):112-8. PubMed ID: 21245532
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of tetrazole analogs of Cl-amidine as protein arginine deiminase inhibitors.
Subramanian V; Knight JS; Parelkar S; Anguish L; Coonrod SA; Kaplan MJ; Thompson PR
J Med Chem; 2015 Feb; 58(3):1337-44. PubMed ID: 25559347
[TBL] [Abstract][Full Text] [Related]
18. Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors.
Knuckley B; Luo Y; Thompson PR
Bioorg Med Chem; 2008 Jan; 16(2):739-45. PubMed ID: 17964793
[TBL] [Abstract][Full Text] [Related]
19. The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors.
Causey CP; Jones JE; Slack JL; Kamei D; Jones LE; Subramanian V; Knuckley B; Ebrahimi P; Chumanevich AA; Luo Y; Hashimoto H; Sato M; Hofseth LJ; Thompson PR
J Med Chem; 2011 Oct; 54(19):6919-35. PubMed ID: 21882827
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for Ca(2+)-induced activation of human PAD4.
Arita K; Hashimoto H; Shimizu T; Nakashima K; Yamada M; Sato M
Nat Struct Mol Biol; 2004 Aug; 11(8):777-83. PubMed ID: 15247907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]